Identification of canine natural CD3-positive T cells expressing an invariant T-cell receptor alpha chain

Veterinary Immunology and Immunopathology

Volumn 132, Issue 2-4, 2009, Pages 224-231

  Yasuda, Nobutaka ^a   Masuda, Kenichi ^a   Tsukui, Tohishiro ^b   Teng, Annabelle ^c   Ishii, Yasuyuki ^c  

^a Animal Allergy Clinical Laboratories   (Japan)

^b ZENYAKU KOGYO CO LTD   (Japan)

^c Institute of Physical and Chemical Research   (Japan)

Author keywords

Dogs; Invariant T cell receptor; Lymphocytes; NKT cells

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; CD3 ANTIGEN; COMPLEMENTARY DNA; CYSTEINE; MESSENGER RNA; T LYMPHOCYTE RECEPTOR ALPHA CHAIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CD3+ T LYMPHOCYTE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; DOG; FEMALE; LIVER CELL; MONONUCLEAR CELL; NATURAL KILLER T CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD1D; ANTIGENS, CD3; BASE SEQUENCE; CONSERVED SEQUENCE; DNA, COMPLEMENTARY; DOGS; GALACTOSYLCERAMIDES; GENE EXPRESSION; GENES, T-CELL RECEPTOR ALPHA; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NATURAL KILLER T-CELLS; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; SPECIES SPECIFICITY; T-LYMPHOCYTE SUBSETS;

CANIS FAMILIARIS; MUS;

EID: 70449522142     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2009.08.002     Document Type: Article

References (55)

1. Akbari O., Stock P., Meyer E., Kronenberg M., Sidobre S., Nakayama T., Taniguchi M., Grusby M.J., DeKruyff R.H., and Umetsu D.T. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 9 (2003) 582-588
2. Arase H., Arase-Fukushi N., Good R.A., and Onoe K. Lymphokine-activated killer cell activity of CD4-CD8- TCR alpha beta + thymocytes. J. Immunol. 151 (1993) 546-555
3. Arase H., Arase N., Nakagawa K., Good R.A., and Onoe K. NK1.1+ CD4+ CD8- thymocytes with specific lymphokine secretion. Eur. J. Immunol. 23 (1993) 307-310
4. Arase H., Arase N., and Saito T. Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking. J. Exp. Med. 183 (1996) 2391-2396
5. Arden B., Clark S.P., Kabelitz D., and Mak T.W. Human T-cell receptor variable gene segment families. Immunogenetics 42 (1995) 455-500
6. Arden B., Clark S.P., Kabelitz D., and Mak T.W. Mouse T-cell receptor variable gene segment families. Immunogenetics 42 (1995) 501-530
7. Babbitt B.P., Allen P.M., Matsueda G., Haber E., and Unanue E.R. Binding of immunogenic peptides to Ia histocompatibility molecules. Nature 317 (1985) 359-361
8. Bendelac A., Rivera M.N., Park S.H., and Roark J.H. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15 (1997) 535-562
9. Benlagha K., Weiss A., Beavis A., Teyton L., and Bendelac A. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191 (2000) 1895-1903
10. Blumberg R.S., Terhorst C., Bleicher P., McDermott F.V., Allan C.H., Landau S.B., Trier J.S., and Balk S.P. Expression of a nonpolymorphic MHC class I-like molecule, CD1D, by human intestinal epithelial cells. J. Immunol. 147 (1991) 2518-2524
11. Borg N.A., Wun K.S., Kjer-Nielsen L., Wilce M.C., Pellicci D.G., Koh R., Besra G.S., Bharadwaj M., Godfrey D.I., McCluskey J., and Rossjohn J. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 448 (2007) 44-49
12. Bradbury A., Belt K.T., Neri T.M., Milstein C., and Calabi F. Mouse CD1 is distinct from and co-exists with TL in the same thymus. EMBO J. 7 (1988) 3081-3086
13. Brossay L., Chioda M., Burdin N., Koezuka Y., Casorati G., Dellabona P., and Kronenberg M. CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188 (1998) 1521-1528
14. Calabi F., Belt K.T., Yu C.Y., Bradbury A., Mandy W.J., and Milstein C. The rabbit CD1 and the evolutionary conservation of the CD1 gene family. Immunogenetics 30 (1989) 370-377
15. Calabi F., Jarvis J.M., Martin L., and Milstein C. Two classes of CD1 genes. Eur. J. Immunol. 19 (1989) 285-292
16. Couedel C., Peyrat M.A., Brossay L., Koezuka Y., Porcelli S.A., Davodeau F., and Bonneville M. Diverse CD1d-restricted reactivity patterns of human T cells bearing "invariant" AV24BV11 TCR. Eur. J. Immunol. 28 (1998) 4391-4397
17. Dellabona P., Casorati G., Friedli B., Angman L., Sallusto F., Tunnacliffe A., Roosneek E., and Lanzavecchia A. In vivo persistence of expanded clones specific for bacterial antigens within the human T cell receptor alpha/beta CD4-8- subset. J. Exp. Med. 177 (1993) 1763-1771
18. Denkers E.Y., Scharton-Kersten T., Barbieri S., Caspar P., and Sher A. A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection. J. Exp. Med. 184 (1996) 131-139
19. Eberl G., Lees R., Smiley S.T., Taniguchi M., Grusby M.J., and MacDonald H.R. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J. Immunol. 162 (1999) 6410-6419
20. Emoto M., Emoto Y., Buchwalow I.B., and Kaufmann S.H. Induction of IFN-gamma-producing CD4+ natural killer T cells by Mycobacterium bovis bacillus Calmette Guerin. Eur. J. Immunol. 29 (1999) 650-659
21. Falcone M., Yeung B., Tucker L., Rodriguez E., and Sarvetnick N. A defect in interleukin 12-induced activation and interferon gamma secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus. J. Exp. Med. 190 (1999) 963-972
22. Flesch I.E., Wandersee A., and Kaufmann S.H. IL-4 secretion by CD4+ NK1+ T cells induces monocyte chemoattractant protein-1 in early listeriosis. J. Immunol. 159 (1997) 7-10
23. Godfrey D.I., and Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114 (2004) 1379-1388
24. Gombert J.M., Herbelin A., Tancrede-Bohin E., Dy M., Chatenoud L., Carnaud C., and Bach J.F. Early defect of immunoregulatory T cells in autoimmune diabetes. C. R. Acad. Sci. III 319 (1996) 125-129
25. Hammond K.J., Poulton L.D., Palmisano L.J., Silveira P.A., Godfrey D.I., and Baxter A.G. alpha/beta-T cell receptor (TCR) + CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med. 187 (1998) 1047-1056
26. Harada M., Seino K., Wakao H., Sakata S., Ishizuka Y., Ito T., Kojo S., Nakayama T., and Taniguchi M. Down-regulation of the invariant Valpha14 antigen receptor in NKT cells upon activation. Int. Immunol. 16 (2004) 241-247
27. Ichimiya S., Kikuchi K., and Matsuura A. Structural analysis of the rat homologue of CD1. Evidence for evolutionary conservation of the CD1D class and widespread transcription by rat cells. J. Immunol. 153 (1994) 1112-1123
28. Imai K., Kanno M., Kimoto H., Shigemoto K., Yamamoto S., and Taniguchi M. Sequence and expression of transcripts of the T-cell antigen receptor alpha-chain gene in a functional, antigen-specific suppressor-T-cell hybridoma. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 8708-8712
29. Ito K., Tsunoda M., Watanabe K., Kashiwagi N., and Obata F. Isolation and sequence analysis of cDNA for the dog T-cell receptor Tcr alpha and Tcr beta chains. Immunogenetics 38 (1993) 60-63
30. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., Ueno H., Nakagawa R., Sato H., Kondo E., Koseki H., and Taniguchi M. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278 (1997) 1626-1629
31. Kjer-Nielsen L., Borg N.A., Pellicci D.G., Beddoe T., Kostenko L., Clements C.S., Williamson N.A., Smyth M.J., Besra G.S., Reid H.H., Bharadwaj M., Godfrey D.I., Rossjohn J., and McCluskey J. A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition. J. Exp. Med. 203 (2006) 661-673
32. Kleinerman E.S., and Herberman R.B. Tumoricidal activity of human monocytes: evidence for cytolytic function distinct from that of NK cells. J. Immunol. 133 (1984) 4-6
33. Kristensen E. The NK function elucidated with respect to effector cells, target cells and other immunological in vitro tests. Tokai J. Exp. Clin. Med. 8 (1983) 449-453
34. Kuppers R.C., and Henney C.S. Studies on the mechanism of lymphocyte-mediated cytolysis. IX. Relationships between antigen recognition and lytic expression in killer T cells. J. Immunol. 118 (1977) 71-76
35. Lantz O., and Bendelac A. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. J. Exp. Med. 180 (1994) 1097-1106
36. Masuda K., Sakaguchi M., Saito S., Yasueda H., Iwabuchi S., Tsukui T., Hayashi N., Nakao Y., Kurata K., Maeda S., Ohno K., and Tsujimoto H. Identification of peptides containing T-cell epitopes of Japanese cedar (Cryptomeria japonica) pollen allergen (Cry j 1) in dogs. Vet. Immunol. Immunopathol. 102 (2004) 45-52
37. Miyamoto K., Miyake S., and Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413 (2001) 531-534
38. Moodycliffe A.M., Nghiem D., Clydesdale G., and Ullrich S.E. Immune suppression and skin cancer development: regulation by NKT cells. Nat. Immunol. 1 (2000) 521-525
39. Morita M., Motoki K., Akimoto K., Natori T., Sakai T., Sawa E., Yamaji K., Koezuka Y., Kobayashi E., and Fukushima H. Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice. J. Med. Chem. 38 (1995) 2176-2187
40. Natori T., Koezuka Y., and Higa T. Agelasphins, novel alpha-galactosylceramides from the marine sponge Agelas mauritianus. Tetrahedron Lett. 34 (1993) 5591-5592
41. Norris S., Collins C., Doherty D.G., Smith F., McEntee G., Traynor O., Nolan N., Hegarty J., and O'Farrelly C. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J. Hepatol. 28 (1998) 84-90
42. Ohteki T., and MacDonald H.R. Major histocompatibility complex class I related molecules control the development of CD4+8- and CD4-8- subsets of natural killer 1.1+ T cell receptor-alpha/beta + cells in the liver of mice. J. Exp. Med. 180 (1994) 699-704
43. Porcelli S., Yockey C.E., Brenner M.B., and Balk S.P. Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. J. Exp. Med. 178 (1993) 1-16
44. Rhind S.M., Hopkins J., and Dutia B.M. Amino-terminal sequencing of sheep CD1 antigens and identification of a sheep CD1D gene. Immunogenetics 49 (1999) 225-230
45. Schofield L., McConville M.J., Hansen D., Campbell A.S., Fraser-Reid B., Grusby M.J., and Tachado S.D. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 283 (1999) 225-229
46. Spada F.M., Koezuka Y., and Porcelli S.A. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J. Exp. Med. 188 (1998) 1529-1534
47. Steimle V., Siegrist C.A., Mottet A., Lisowska-Grospierre B., and Mach B. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265 (1994) 106-109
48. Sumida T., Sakamoto A., Murata H., Makino Y., Takahashi H., Yoshida S., Nishioka K., Iwamoto I., and Taniguchi M. Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis. J. Exp. Med. 182 (1995) 1163-1168
49. Takahashi T., Nieda M., Koezuka Y., Nicol A., Porcelli S.A., Ishikawa Y., Tadokoro K., Hirai H., and Juji T. Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells. J. Immunol. 164 (2000) 4458-4464
50. Terabe M., Matsui S., Noben-Trauth N., Chen H., Watson C., Donaldson D.D., Carbone D.P., Paul W.E., and Berzofsky J.A. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat. Immunol. 1 (2000) 515-520
51. Watarai H., Nakagawa R., Omori-Miyake M., Dashtsoodol N., and Taniguchi M. Methods for detection, isolation and culture of mouse and human invariant NKT cells. Nat. Protoc. 3 (2008) 70-78
52. Wilson S.B., Kent S.C., Patton K.T., Orban T., Jackson R.A., Exley M., Porcelli S., Schatz D.A., Atkinson M.A., Balk S.P., Strominger J.L., and Hafler D.A. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 391 (1998) 177-181
53. Yoshimoto T., Bendelac A., Watson C., Hu-Li J., and Paul W.E. Role of NK1.1+ T cells in a TH2 response and in immunoglobulin E production. Science 270 (1995) 1845-1847
54. Zeng D., Lewis D., Dejbakhsh-Jones S., Lan F., Garcia-Ojeda M., Sibley R., and Strober S. Bone marrow NK1.1(-) and NK1. 1(+) T cells reciprocally regulate acute graft versus host disease. J. Exp. Med. 189 (1999) 1073-1081
55. Zlotnik A., Godfrey D.I., Fischer M., and Suda T. Cytokine production by mature and immature CD4-CD8- T cells. Alpha beta-T cell receptor + CD4-CD8- T cells produce IL-4. J. Immunol. 149 (1992) 1211-1215